On Jan. 21, Avalanche announced the launch of the C-Chain round of Retro9000, the retroactive grant program that rewards up ...

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

If you’re going to be a hacker, learning C is a rite of passage. If you don’t have much experience with C, or if your experience is out of date, you very well may benefit from hearing [Nic Barker] ...

NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with ...

Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today announced ...

HiBird makes its debut at this year's McLane Engage trade show. HiBird products boast a long shelf life and the flexibility to be prepared in either a fryer or rapid cook oven and can be adapted to ...

– Company Eligible to Receive Up to $25 Million, Including an Upfront Equity Payment of $7.5 Million – – Extends Rallybio Cash Runway to Mid-2027 – NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio ...

– Company Eligible to Receive Up to $25 Million, Including an Upfront Equity Payment of $7.5 Million – – Extends Rallybio Cash Runway to Mid-2027 – Rallybio Corporation (Nasdaq: RLYB), a ...

In New Assessment, C.I.A. Chief Says U.S. Strikes ‘Severely Damaged’ Iranian Program The administration suggested an initial report of less-severe damage was already outdated as the president ...